NXN-462
- Generic Name
- NXN-462
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 188
- Registration Number
- NCT01748877
- Locations
- 🇺🇸
Neurological Research Institute, Santa Monica, California, United States
🇺🇸FPA Clinical Research, Kissimmee, Florida, United States
🇨🇦Manna Research, Inc., Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath